141 related articles for article (PubMed ID: 7803281)
1. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.
Burger H; Nooter K; Sonneveld P; Van Wingerden KE; Zaman GJ; Stoter G
Br J Haematol; 1994 Oct; 88(2):348-56. PubMed ID: 7803281
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance-associated protein (MRP) in haematological malignancies.
Nooter K; Burger H; Stoter G
Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
[TBL] [Abstract][Full Text] [Related]
3. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
[TBL] [Abstract][Full Text] [Related]
4. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.
Beck J; Niethammer D; Gekeler V
Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350
[TBL] [Abstract][Full Text] [Related]
5. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
Clifford SC; Neal DE; Lunec J
Br J Cancer; 1996 Mar; 73(5):659-66. PubMed ID: 8605104
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic studies in chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia: a progress report.
Han T; Sadamori N; Block AM; Xiao H; Henderson ES; Emrich L; Sandberg AA
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):393-5. PubMed ID: 3222149
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
8. Bcl10 in chronic lymphocytic leukaemia and T-cell prolymphocytic leukaemia.
Yuille MR; Stone JG; Bradshaw PS; Houlston RS
Br J Haematol; 1999 Nov; 107(2):384-5. PubMed ID: 10583229
[TBL] [Abstract][Full Text] [Related]
9. MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders.
Webb M; Brun M; McNiven M; Le Couteur D; Craft P
Br J Haematol; 1998 Aug; 102(3):710-7. PubMed ID: 9722297
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance mechanisms in chronic lymphocytic leukaemia.
Consoli U; Santonocito A; Stagno F; Fiumara P; Privitera A; Parisi G; Giustolisi GM; Pavone B; Palumbo GA; Di Raimondo F; Milone G; Guglielmo P; Giustolisi R
Br J Haematol; 2002 Mar; 116(4):774-80. PubMed ID: 11886380
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.
Abe T; Hasegawa S; Taniguchi K; Yokomizo A; Kuwano T; Ono M; Mori T; Hori S; Kohno K; Kuwano M
Int J Cancer; 1994 Sep; 58(6):860-4. PubMed ID: 7927879
[TBL] [Abstract][Full Text] [Related]
12. Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Langabeer SE; Quinn F; O'Brien D; McElligott AM; Kelly J; Browne PV; Vandenberghe E
Leuk Res; 2012 Apr; 36(4):483-4. PubMed ID: 22230299
[TBL] [Abstract][Full Text] [Related]
13. Expression of mdr1 and mrp in the normal B-cell homologue of B-cell chronic lymphocytic leukaemia.
Wall DM; el-Osta S; Tzelepis D; Bertoncello I; Kantharidis P; Chou ST; Zalcberg JR; Parkin JD
Br J Haematol; 1997 Mar; 96(4):697-707. PubMed ID: 9074409
[TBL] [Abstract][Full Text] [Related]
14. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.
Stewart AJ; Canitrot Y; Baracchini E; Dean NM; Deeley RG; Cole SP
Biochem Pharmacol; 1996 Feb; 51(4):461-9. PubMed ID: 8619891
[TBL] [Abstract][Full Text] [Related]
15. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
16. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Herweijer H; Sonneveld P; Baas F; Nooter K
J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761
[TBL] [Abstract][Full Text] [Related]
17. A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues.
Schwarzenbach H
Anal Biochem; 2002 Sep; 308(1):26-33. PubMed ID: 12234460
[TBL] [Abstract][Full Text] [Related]
18. Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia.
Hart SM; Ganeshaguru K; Hoffbrand AV; Prentice HG; Mehta AB
Leukemia; 1994 Dec; 8(12):2163-8. PubMed ID: 7808005
[TBL] [Abstract][Full Text] [Related]
19. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
Beck J; Handgretinger R; Dopfer R; Klingebiel T; Niethammer D; Gekeler V
Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
